|
| |
EPA
& DHA: Omega-3 Fatty Acids
(eicosapentaenoic acid
& docosahexaenoic acid)
DRI (RDA or AI for Adults)
- None. As alpha-linolenic acid (precursor to
EPA & DHA):
Males: 1.6 g. Females: 1.1 g. Pregnancy: 1.4 g. Lactation: 1.3
g.
Adult Maintenance - Therapeutic Range
- 500 - 3,000 mg of EPA/DHA. (Fish oil caps usually contain
18-30% EPA and 12-20% DHA.)
Major Sources
- Cold-water fish, such as salmon, tuna, mackerel, halibut,
and herring. Flaxseed oil (and to a lesser extent, canola and soybean oils) contains the
essential fatty acid, alpha-linolenic acid (ALA), a precursor to EPA and DHA, but humans
convert ALA to EPA and DHA very inefficiently (about 10%).
Non-Therapeutic Importance
- Essential fatty acids (EFA) are precursors of the
hormone-like eicosanoids (prostaglandins, thromboxanes, leukotrienes) that participate in
the regulation of blood pressure, heart rate, vascular dilation, blood clotting,
lipolysis, immune response, and the central nervous system. Omega-3 fatty acids balance
the action of arachidonic acid (excess metabolites can cause inflammation).
Possible Therapeutic Applications
CONSULT WITH A HEALTH PROFESSIONAL FIRST: HIGH
DOSAGE NOTE: Consult first with your physician if you have diabetes or are taking blood
thinning drugs. Supplementation may prevent, correct deficiencies caused
by, or be helpful with, the following conditions:
- Aging
- Angina Pectoris
- Anxiety
- Asthma
- Atherosclerosis (heart disease)
- Cardiac Arrhythmias
- Cerebrovascular Disease (including stroke)
- Chronic Fatigue Syndrome (CFS, CFIDS)
- Crohn's Disease
- Diabetes
- Eczema
- Headache (migraine)
- Hypertension (high blood pressure)
- Immunodepression (immune function)
- Infection (colds, flu, etc.)
- Inflammation (including bursitis)
- Kidney Stones
- Learning Disorders (including ADHD)
- Lupus (SLE)
- Memory Loss (Alzheimer's disease, dementia)
- Multiple Sclerosis (MS)
- Osteoarthritis
- Osteoporosis
- Peptic Ulcers
- Psoriasis
- Raynaud's Disease
- Rheumatoid Arthritis
- Ulcerative Colitis
|